 |
Market Cap | 1.01B | EPS (ttm) | 0.87 |
P/E | 32.47 | EPS this Y | 36.36% |
Forward P/E | 21.53 | EPS next Y | 9.40% |
PEG | 1.55 | EPS past 5Y | - |
P/S | 2.02 | EPS next 5Y | 20.90% |
P/B | 7.44 | EPS Q/Q | 277.59% |
Dividend | - | Sales Q/Q | 164.71% |
Insider Own | 27.75% | Inst Own | 72.53% |
Insider Trans | -1.68% | Inst Trans | -6.09% |
Short Float | 5.56% | Earnings | Feb 24/a |
Analyst Recom | 1.50 | Target Price | 33.83 |
Avg Volume | 554.28K | 52W Range | 16.63 - 28.27 |
|
|
|
EverQuote, Inc. operates as an online insurance marketplace connecting consumers with insurance providers. It offers car, home and life insurance. The firm's data and technology platform matches and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. The company was founded by Seth N. Birnbaum, David B. Blundin, and Tomas Revesz in August 1, 2008 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
LINK VENTURES, LLLP | Shareholder | Mar 19 '25 | Proposed Sale | 26.46 | 10,422 | 275,766 | | Mar 19 06:08 PM | Recognition Capital, LLC | Shareholder | Mar 19 '25 | Proposed Sale | 26.46 | 100,402 | 2,656,637 | | Mar 19 05:59 PM | BLUNDIN DAVID B | Shareholder | Mar 19 '25 | Proposed Sale | 26.46 | 89,177 | 2,359,623 | | Mar 19 05:52 PM | Ayotte Jon | Chief Accounting Officer | Mar 17 '25 | Sale | 27.90 | 1,217 | 33,954 | 56,828 | Mar 18 04:30 PM | JON D AYOTTE | Officer | Mar 17 '25 | Proposed Sale | 26.61 | 1,217 | 32,384 | | Mar 17 04:34 PM |
|
|
 |
 |
Market Cap | 51.55B | EPS (ttm) | 7.03 |
P/E | 37.82 | EPS this Y | 12.18% |
Forward P/E | 15.72 | EPS next Y | 9.55% |
PEG | 3.59 | EPS past 5Y | 13.29% |
P/S | 0.17 | EPS next 5Y | 10.52% |
P/B | 227.41 | EPS Q/Q | -16.00% |
Dividend | 0.74% | Sales Q/Q | 12.78% |
Insider Own | 6.87% | Inst Own | 91.40% |
Insider Trans | -9.60% | Inst Trans | 0.73% |
Short Float | 3.84% | Earnings | Feb 05/b |
Analyst Recom | 1.84 | Target Price | 284.07 |
Avg Volume | 1.47M | 52W Range | 214.77 - 265.44 |
|
|
|
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mauch Robert P. | President & CEO | Mar 18 '25 | Option Exercise | 86.09 | 3,226 | 277,726 | 54,296 | Mar 19 04:38 PM | Mauch Robert P. | President & CEO | Mar 18 '25 | Sale | 260.93 | 4,970 | 1,296,822 | 49,326 | Mar 19 04:38 PM | Mauch Robert P. | Officer | Mar 18 '25 | Proposed Sale | 260.93 | 4,970 | 1,296,822 | | Mar 18 12:05 PM | Krikorian Lazarus | SVP & Chief Accounting Officer | Mar 10 '25 | Sale | 260.06 | 2,000 | 520,120 | 20,154 | Mar 11 04:07 PM | Krikorian Lazarus | Officer | Mar 10 '25 | Proposed Sale | 260.06 | 2,000 | 520,120 | | Mar 10 02:09 PM |
|
|
 |
 |
Market Cap | 8.48B | EPS (ttm) | 0.83 |
P/E | 21.48 | EPS this Y | 16.48% |
Forward P/E | 16.15 | EPS next Y | 13.46% |
PEG | 1.61 | EPS past 5Y | - |
P/S | 7.21 | EPS next 5Y | 13.33% |
P/B | 4.02 | EPS Q/Q | 10.13% |
Dividend | 5.14% | Sales Q/Q | 9.83% |
Insider Own | 30.45% | Inst Own | 57.33% |
Insider Trans | -0.01% | Inst Trans | 2.54% |
Short Float | 4.49% | Earnings | Feb 12/a |
Analyst Recom | 3.56 | Target Price | 16.21 |
Avg Volume | 3.17M | 52W Range | 13.12 - 17.63 |
|
|
|
Antero Midstream Corp. is a growth-oriented midstream energy company, which owns, operates, and develops midstream energy assets to service Antero Resources production and completion activity. It operates through the Gathering and Processing and Water Handling segments. The Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio. It also includes equity in earnings from the company's investments in the Joint Venture and Stonewall. The Water Handling segment focuses on two independent systems that deliver fresh water from sources including the Ohio River, local reservoirs, and several regional waterways. The company was founded on September 23, 2013 and is headquartered in Denver, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MCARDLE JANINE J | Director | Dec 13 '24 | Buy | 15.11 | 1,174 | 17,739 | 68,320 | Dec 16 06:50 PM | KLIMLEY BROOKS J | Director | Nov 05 '24 | Sale | 14.66 | 10,000 | 146,600 | 74,100 | Nov 06 08:32 PM | BROOKS J KLIMLEY | Director | Nov 05 '24 | Proposed Sale | 14.66 | 10,000 | 146,552 | | Nov 05 04:56 PM | Pearce Sheri | See Remarks | Aug 21 '24 | Sale | 14.59 | 23,518 | 343,128 | 130,349 | Aug 22 07:51 PM |
|
|
|  |
 |
Market Cap | 74.57B | EPS (ttm) | 0.46 |
P/E | 12.80 | EPS this Y | 34.68% |
Forward P/E | 11.54 | EPS next Y | 10.39% |
PEG | 0.71 | EPS past 5Y | 40.08% |
P/S | 1.25 | EPS next 5Y | 18.00% |
P/B | 1.12 | EPS Q/Q | 24.07% |
Dividend | 2.92% | Sales Q/Q | 15.74% |
Insider Own | 0.01% | Inst Own | 1.28% |
Insider Trans | 0.00% | Inst Trans | 0.12% |
Short Float | 0.01% | Earnings | Feb 03/a |
Analyst Recom | 1.75 | Target Price | 5.96 |
Avg Volume | 1.37M | 52W Range | 3.45 - 5.91 |
|
|
|
Mizuho Financial Group, Inc. operates as a holding company which engages in the provision of financial services such as banking, trust banking, securities, and others. It operates through the following segments: Mizuho Bank Ltd. (MHKB), Mizuho Trust & Banking Co., Ltd. (MHTB), and Mizuho Securities Co., Ltd. (MHSC). The Mizuho Bank Ltd. segment includes personal, retail, corporate, international banking, financial institutions, public sector, and trading services. The Mizuho Trust & Banking Co., Ltd. provides services related to trust, real estate, securitization, structured finance, pension and asset management, and stock transfer agency. The Mizuho Securities Co., Ltd. offers security services to individuals, corporations, financial institutions and public sector entities. The company was founded in 1864 and is headquartered in Tokyo, Japan. |
|
 |
 |
Market Cap | 7.50B | EPS (ttm) | 5.79 |
P/E | 8.23 | EPS this Y | 18.89% |
Forward P/E | 6.24 | EPS next Y | 12.55% |
PEG | 0.58 | EPS past 5Y | 18.00% |
P/S | 3.14 | EPS next 5Y | 14.26% |
P/B | 2.30 | EPS Q/Q | 93.58% |
Dividend | 3.72% | Sales Q/Q | 0.25% |
Insider Own | 8.57% | Inst Own | 58.70% |
Insider Trans | 0.00% | Inst Trans | -0.10% |
Short Float | 2.51% | Earnings | Mar 17/b |
Analyst Recom | 1.15 | Target Price | 53.56 |
Avg Volume | 1.27M | 52W Range | 17.76 - 48.50 |
|
|
|
Qifu Technology. Inc. is a holding company, which engages in the provision of digital consumer finance platforms. It provides tailored online consumer finance products to prime, underserved borrowers funded primarily by its funding partners. The company's proprietary technology platform supports full transaction lifecycle from credit application through settlement. The company was founded on July 25, 2016 and is headquartered in Shanghai, China. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Yan Zheng | Officer | Dec 03 '24 | Proposed Sale | 37.88 | 483,000 | 18,296,040 | | Dec 02 07:26 AM | Holy Vanguard Ltd | Officer | Dec 03 '24 | Proposed Sale | 37.88 | 1,200,000 | 45,456,000 | | Dec 02 07:22 AM | Andrew Y Yan | Director | Sep 05 '24 | Proposed Sale | 26.49 | 800,000 | 21,192,000 | | Sep 05 06:54 AM | Zhiqiang He | Officer | Sep 06 '24 | Proposed Sale | 25.90 | 196,853 | 5,098,493 | | Sep 04 09:41 PM | Yan Zheng | Officer | Aug 23 '24 | Proposed Sale | 24.84 | 250,000 | 6,210,000 | | Aug 22 09:46 PM |
|
|
|  |
 |
Market Cap | 165.89B | EPS (ttm) | 1.09 |
P/E | 13.07 | EPS this Y | 33.70% |
Forward P/E | 12.37 | EPS next Y | 7.78% |
PEG | 0.83 | EPS past 5Y | 7.39% |
P/S | 1.99 | EPS next 5Y | 15.81% |
P/B | 1.28 | EPS Q/Q | 32.39% |
Dividend | 2.81% | Sales Q/Q | 7.46% |
Insider Own | 0.02% | Inst Own | 7.26% |
Insider Trans | 0.00% | Inst Trans | -0.37% |
Short Float | 0.09% | Earnings | Feb 04/a |
Analyst Recom | 1.88 | Target Price | 14.16 |
Avg Volume | 4.47M | 52W Range | 8.75 - 14.36 |
|
|
|
Mitsubishi UFJ Financial Group, Inc. operates as a holding company, which provides financial services through its subsidiaries. It operates through the following segments: Integrated Retail Banking Business Group, Integrated Corporate Banking Business Group, Integrated Trust Assets Business Group, Integrated Global Business Group, Global Markets and Others. The Integrated Retail Banking Business Group segment manages domestic business that provides retail banking services, which includes commercial and trust banking; securities trading; and retail product development, promotions, and marketing. The Integrated Corporate Banking Business Group segment covers all domestic corporate businesses, including commercial banking, investment banking, trust banking, and securities businesses. The Integrated Trust Assets Business Group segment provides asset management and administration services for pension and security trusts, in addition to consultation services for pension management schemes and payouts. The Integrated Global Business Group segment covers businesses outside of Japan. The Global Markets segment offers assets and liability management, strategic investment, foreign exchange operations and financial products. The Others segment operates corporate centers of related companies. The company was founded on April 2, 2001 and is headquartered in Tokyo, Japan. |
|
 |
 |
Market Cap | 5.37B | EPS (ttm) | 1.46 |
P/E | 21.38 | EPS this Y | 70.78% |
Forward P/E | 8.81 | EPS next Y | 11.41% |
PEG | 0.60 | EPS past 5Y | 20.47% |
P/S | 0.93 | EPS next 5Y | 35.43% |
P/B | 1.46 | EPS Q/Q | 148.94% |
Dividend | 8.94% | Sales Q/Q | -3.19% |
Insider Own | 41.95% | Inst Own | 6.78% |
Insider Trans | 0.00% | Inst Trans | -5.28% |
Short Float | 0.80% | Earnings | Feb 27/b |
Analyst Recom | 1.58 | Target Price | 34.36 |
Avg Volume | 519.42K | 52W Range | 19.03 - 31.46 |
|
|
|
Millicom International Cellular SA engages in the cable and mobile services. It operates through the Latin America and Africa geographical segments. The Latin America segment includes the Guatemala and Honduras joint ventures. The Africa segment comprises of the operations in Tanzania. The company was founded on December 14, 1990 and is headquartered in Luxembourg. |
|
|  |
 |
Market Cap | 83.19B | EPS (ttm) | 21.82 |
P/E | 30.42 | EPS this Y | 19.40% |
Forward P/E | 18.01 | EPS next Y | 12.47% |
PEG | 2.07 | EPS past 5Y | 164.60% |
P/S | 0.24 | EPS next 5Y | 14.71% |
P/B | - | EPS Q/Q | 57.13% |
Dividend | 0.40% | Sales Q/Q | 17.80% |
Insider Own | 0.09% | Inst Own | 88.65% |
Insider Trans | -24.95% | Inst Trans | -0.53% |
Short Float | 1.47% | Earnings | Feb 05/a |
Analyst Recom | 1.63 | Target Price | 685.64 |
Avg Volume | 799.00K | 52W Range | 464.42 - 663.61 |
|
|
|
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
TYLER BRIAN S. | Chief Executive Officer | Mar 06 '25 | Sale | 634.24 | 8,962 | 5,684,059 | 42,741 | Mar 07 03:30 PM | TYLER BRIAN S. | Officer | Mar 06 '25 | Proposed Sale | 634.24 | 8,962 | 5,684,059 | | Mar 06 01:22 PM | Rutledge Napoleon B JR | SVP, Controller & CAO | Mar 01 '25 | Option Exercise | 0.00 | 786 | 0 | 2,698 | Mar 03 04:49 PM | TYLER BRIAN S. | Chief Executive Officer | Feb 28 '25 | Sale | 624.00 | 8,961 | 5,591,664 | 51,703 | Mar 03 04:48 PM | TYLER BRIAN S. | Officer | Feb 28 '25 | Proposed Sale | 624.00 | 8,961 | 5,591,664 | | Feb 28 11:26 AM |
|
|
 |
 |
Market Cap | 1.05B | EPS (ttm) | -3.64 |
P/E | - | EPS this Y | -6.33% |
Forward P/E | - | EPS next Y | -1.88% |
PEG | - | EPS past 5Y | -170.42% |
P/S | - | EPS next 5Y | -3.06% |
P/B | 4.36 | EPS Q/Q | -61.06% |
Dividend | - | Sales Q/Q | - |
Insider Own | 50.62% | Inst Own | 43.38% |
Insider Trans | 8.21% | Inst Trans | 6.36% |
Short Float | 6.49% | Earnings | Feb 12/b |
Analyst Recom | 1.00 | Target Price | 36.71 |
Avg Volume | 754.19K | 52W Range | 8.24 - 18.29 |
|
|
|
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Samsara BioCapital GP, LLC | 10% Owner | Mar 13 '25 | Buy | 13.50 | 600,000 | 8,100,000 | 5,674,916 | Mar 17 09:05 PM | AKKARAJU SRINIVAS | Director | Mar 13 '25 | Buy | 13.50 | 600,000 | 8,100,000 | 5,674,916 | Mar 17 09:04 PM | RA CAPITAL MANAGEMENT, L.P. | Director | Mar 13 '25 | Buy | 13.50 | 1,296,296 | 17,499,996 | 4,280,051 | Mar 17 07:56 PM | Rodman David Malcom | Chief Medical Officer | Mar 12 '25 | Option Exercise | 1.08 | 6,349 | 6,857 | 170,869 | Mar 13 05:15 PM | Rodman David Malcom | Chief Medical Officer | Feb 12 '25 | Option Exercise | 1.08 | 6,348 | 6,856 | 164,520 | Feb 13 05:29 PM |
|
|
 |
 |
Market Cap | 95.66B | EPS (ttm) | 9.67 |
P/E | 27.45 | EPS this Y | 3.27% |
Forward P/E | 23.72 | EPS next Y | 5.65% |
PEG | 5.04 | EPS past 5Y | 10.36% |
P/S | 15.61 | EPS next 5Y | 5.45% |
P/B | 3.60 | EPS Q/Q | 7.28% |
Dividend | 3.82% | Sales Q/Q | 5.98% |
Insider Own | 0.31% | Inst Own | 89.44% |
Insider Trans | -5.87% | Inst Trans | 0.86% |
Short Float | 1.40% | Earnings | Feb 12/b |
Analyst Recom | 2.55 | Target Price | 259.24 |
Avg Volume | 2.02M | 52W Range | 186.08 - 266.63 |
|
|
|
CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lucas Deborah J | Director | Mar 14 '25 | Sale | 256.95 | 1,500 | 385,425 | 3,356 | Mar 18 12:19 PM | SIEGEL HOWARD J | Director | Mar 13 '25 | Sale | 260.00 | 10,000 | 2,600,000 | 21,873 | Mar 17 02:01 PM | Lucas Deborah J | Director | Mar 14 '25 | Proposed Sale | 259.00 | 1,500 | 388,500 | | Mar 14 09:43 AM | SIEGEL HOWARD J | Director | Mar 12 '25 | Proposed Sale | 255.67 | 20,000 | 5,113,400 | | Mar 12 03:20 PM | DUFFY TERRENCE A | Chairman and CEO | Mar 11 '25 | Sale | 259.18 | 30,000 | 7,775,400 | 53,205 | Mar 11 04:44 PM |
|
|
|